Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.
Roland Bruno WalterLaura C MichaelisMegan OthusGeoffrey L UyJerald P RadichRichard F LittleSandi HitaLalit SainiJames M ForanAaron T GerdsHeidi D KlepinAnnette E HaySarit AssoulineJeffrey E LancetStephen CoubanMark R LitzowRichard M StoneHarry P ErbaPublished in: American journal of hematology (2017)